
Journal of labelled compounds and radiopharmaceuticals p. 1157 - 1164 (1994)
Update date:2022-08-25
Topics:
McKendry
Stanga
Two new processes were developed for the synthesis of 2,6-dichloro-3-methylaniline-Ph-UL-14C (1), a key intermediate in the synthesis of a DowElanco experimental product presently being considered for commercialization. Both processes afford product in much higher yields than that previously reported in the literature. One of the processes was subsequenly applied to the synthesis of methyl 6-chloroanthranilate-Ph-14C (12), used as an intermediate for a second potential product.
View More
Chongqing KonAo Health Co.,Ltd
Contact:13687578375
Address:wuhan hubei china
ZhangJiaGang YaRui Chemical Co.,Ltd.
Contact:0512-58360968
Address:China JiangSu Province Zhang Jia Gang City YangShe Oriental Plaza Building 10 B307
Contact:+86-571-86025531 / 86024803
Address:1218-24 Guangyin Mansion,42 Fengqi East Road
Tianjin Bright Future Technology Co., Ltd
Contact:0086-22-58016666
Address:NO.136 DongTeng Lake Street Tianjin Economic and Technology Development Area,Tainjin,China
Nanjing Legend Pharmaceutical & Chemical Co., Ltd.
Contact:+86-25-83767696
Address:14-7 Zhongshan Lu Guluo District, Nanjing
Doi:10.1134/S003602360812005X
(2008)Doi:10.1134/S1070427206110218
(2006)Doi:10.1021/ja01365a025
(1930)Doi:10.1016/S0022-1139(97)00117-6
(1998)Doi:10.1246/bcsj.48.1097
(1975)Doi:10.1016/j.bmcl.2013.09.097
(2013)